Form 4: Omega Healthcare Investors Director Burke W. Whitman Acquires Shares as Part of Compensation

Director Burke W. Whitman acquired 4,605 shares of Omega Healthcare Investors, Inc. common stock as part of director compensation.

Summary

• On June 7, 2024, Burke W. Whitman, a director of Omega Healthcare Investors, Inc., acquired 4,605 shares of common stock.
• The acquisition was part of director compensation, with the shares priced at $32.57 each.
• Following the transaction, Whitman directly owns 39,765 shares of Omega Healthcare Investors, Inc.
• The shares were granted via a Restricted Stock Grant Award Agreement and will vest approximately one year from the grant date, at the company's 2025 Annual Meeting of Shareholders.
• Whitman has a power of attorney agreement in place, effective February 9, 2022, allowing designated attorneys-in-fact to handle SEC filings on his behalf.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's part of a compensation package, so it's not necessarily indicative of exceptional confidence.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The restricted stock grant aligns the director's interests with those of the shareholders, encouraging long-term value creation.

Future Outlook

The restricted stock will vest approximately one year from the grant date, at the company's 2025 Annual Meeting of Shareholders.

Industry Context

Director share acquisitions are common in the healthcare REIT sector as part of compensation packages, aligning management interests with shareholder value.

Comparison to Industry Standards

• Comparing director compensation packages across similar healthcare REITs like Welltower (WELL) and Ventas (VTR) would provide context on the size and structure of the stock grant.
• Analyzing the vesting schedules and performance metrics associated with these grants in comparison to industry norms can offer insights into the alignment of incentives.

Stakeholder Impact

• Shareholders may view the director's stock acquisition positively, as it aligns management's interests with their own.
• The transaction has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates